LDI may be considered for patients with allergies, sensitivities, autoimmune conditions, chronic inflammation, or other immune-related concerns. However, having one of these conditions does not necessarily mean LDI is the right treatment for you.

During your initial consultation, we'll review your health history, symptoms, previous treatments, and individual goals to determine whether LDI may be an appropriate option and discuss what you can realistically expect from treatment.

LDI is administered sublingually, meaning the treatment is placed under the tongue. There are no injections or allergy shots required.

You'll receive clear instructions for administering each dose at home, along with guidance on timing and what to expect before and after treatment.

LDI is typically administered at spaced intervals rather than on a daily or weekly basis. The timing of each dose is individualized based on your treatment plan and how you respond.

Finding the right dose may take time, and treatment intervals can change as your care progresses. You'll receive specific guidance from Aurora about when to take each dose and when follow-up is needed.

Every patient responds differently. Some patients may notice improvement after an early dose, while others require several treatment cycles to identify the dose that works best for them.

LDI is a highly individualized process, and finding the right dose can take time. We'll monitor your response throughout treatment and make adjustments when appropriate. Our goal is to approach treatment thoughtfully and conservatively rather than rush the process.

LDI dosing is highly individualized. Your starting dose is selected based on your medical history, symptoms, sensitivities, and the specific antigens being considered.

After each treatment, we'll evaluate how you responded before determining the next step. Depending on your response, the dose may be maintained or adjusted over time. The goal is to identify the dose that provides the best response while minimizing the potential for unwanted symptoms.

An LDI flare is a temporary increase in symptoms that can occur if the immune system responds too strongly to a dose. While not everyone experiences a flare, it can provide useful information when determining the most appropriate dose for future treatment.

At Aurora, we take a conservative approach to dosing with the goal of minimizing the likelihood and severity of a flare. If you notice a change in symptoms after treatment, we'll guide you on what to do and use your response to help inform future dosing decisions.

Yes. Low Dose Immunotherapy may be considered for both children and adults when clinically appropriate. Because LDI is administered under the tongue and does not require injections, treatment can be relatively simple for families to administer at home.

For pediatric patients, we take an especially conservative approach to dosing and carefully consider the child's health history, symptoms, and sensitivities when developing a treatment plan.

Not necessarily. During your consultation, we'll review your current medications and supplements and discuss whether any changes or special considerations are recommended around the time of your LDI treatment.

You should not stop or change a prescribed medication unless instructed to do so by the healthcare provider managing that medication. We'll provide individualized guidance based on your treatment plan.

No. Low Dose Immunotherapy (LDI) is not an FDA-approved treatment. It is an individualized approach used by some healthcare providers for patients with allergies and other immune-related conditions.

At Aurora, we believe patients should understand the nature of any treatment they are considering, including its potential benefits, limitations, and alternatives. These are discussed as part of the consultation and informed consent process before beginning treatment.